Exelon is an effective medication for the treatment of confusion related to Alzheimer's disease and to Parkinson's disease. This drug has an active ingredient Rivastigmine Tartrate, which is a cholinesterase inhibitor. This medicine is manufactured by the trusted pharmaceutical company, Novartis Pharmaceuticals Corporation. It is offered in dosages as 1.5 mg, 3 mg, 4.5 mg, and 6 mg in the form of a conventional tablet.
Manufacturer: Novartis Pharmaceuticals Corporation
Active Ingredient: Rivastigmine Tartrate is the main active ingredient in this medicine. This drug exhibits cognitive stimulating property. The exact mechanism of the working of this medication is not known. This active ingredient may bind reversibly to cholinesterase so as to reduce the breakdown of acetylcholine and enhancing cholinergic function. It is a tartrate salt obtained by reaction of rivastigmine with one equivalent of tartaric acid. A reversible cholinesterase inhibitor plays the role of a cholinergic drug, cholinesterase inhibitor and, a neuroprotective agent.
Indications: Rivastigmine composed medicine is indicated to treat confusion related to Alzheimer's disease and to Parkinson's disease. Exelon does not cure either of these diseases. It may improve memory, awareness, and the ability to perform daily functions. It works by restoring the balance of natural substances in the brain.
Action Mechanism: Given medicine is a cholinesterase inhibitor. Exelon inhibits both butyrylcholinesterase and acetylcholinesterase. It works by inhibiting these cholinesterase enzymes, which would otherwise break down the brain neurotransmitter acetylcholine.
Dosages: Given effective medicine is available in dosages as mentioned below:
- 1.5 mg: It is to be consumed twice a day with food in the morning and evening as directed by the doctor
- 3 mg: It is advised to be taken twice a day with food as prescribed by the doctor
- 4.5 mg: This medicine should be taken twice a day directed by the doctor
- 6 mg: It is to be taken twice a day as mentioned in the prescription by the doctor
Note: This drug should not be given in people who have ever had severe redness, itching, or skin irritation caused by wearing a rivastigmine transdermal skin patch.